FDA Orange Book · active-ingredient family
Ampicillin/ampicillin trihydrate
Ampicillin/ampicillin trihydrate is approved as 5 brand and 34 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.
Reference-listed drug:PRINCIPEN '250' · NDA 050056
5
Brand (NDA)
34
Generics (ANDA)
0
Listed patents
0
Exclusivity periods
Brand (NDA) products · capsule, for suspension, tablet, chewable
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| PRINCIPEN '250'RLD×2 | APOTHECON | NDA 050056 | — | Approved Prior to Jan 1, 1982 | |
| POLYCILLIN×2 | BRISTOL | NDA 050310 | — | Approved Prior to Jan 1, 1982 | |
| PENBRITIN×3 | WYETH AYERST | NDA 050019 | — | Approved Prior to Jan 1, 1982 | |
| POLYCILLIN×4 | BRISTOL | NDA 050308 | — | Approved Prior to Jan 1, 1982 | |
| POLYCILLIN | BRISTOL | NDA 050093 | — | Approved Prior to Jan 1, 1982 |
Generic (ANDA) products (34)
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| AMPICILLIN TRIHYDRATE×2 | AUROBINDO PHARMA | ANDA 216554 | — | Oct 31, 2023 | |
| AMPICILLIN TRIHYDRATE×2 | SANDOZ | ANDA 064082 | — | Aug 29, 1995 | |
| AMPICILLIN TRIHYDRATE×2 | PH HEALTH | ANDA 062982 | — | Feb 10, 1989 | |
| PRINCIPEN×2 | APOTHECON | ANDA 062888 | — | Mar 04, 1988 | |
| AMPICILLIN TRIHYDRATE | STRIDES PHARMA INTL | ANDA 062883 | — | Feb 25, 1988 | |
| AMPICILLIN TRIHYDRATE | STRIDES PHARMA INTL | ANDA 062882 | — | Feb 25, 1988 | |
| AMCILL×2 | PARKE DAVIS | ANDA 062041 | — | Approved Prior to Jan 1, 1982 | |
| AMPICILLIN TRIHYDRATE×2 | BELCHER PHARMS | ANDA 061602 | — | Approved Prior to Jan 1, 1982 | |
| AMPICILLIN TRIHYDRATE×2 | CHARTWELL RX | ANDA 061502 | — | Approved Prior to Jan 1, 1982 | |
| AMPICILLIN TRIHYDRATE×2 | IVAX SUB TEVA PHARMS | ANDA 060765 | — | Approved Prior to Jan 1, 1982 | |
| AMPICILLIN TRIHYDRATE×2 | LEDERLE | ANDA 062208 | — | Approved Prior to Jan 1, 1982 | |
| AMPICILLIN TRIHYDRATE×2 | MYLAN | ANDA 061755 | — | Approved Prior to Jan 1, 1982 | |
| AMPICILLIN TRIHYDRATE×2 | PUREPAC PHARM | ANDA 061853 | — | Approved Prior to Jan 1, 1982 | |
| AMPICILLIN TRIHYDRATE×2 | VITARINE | ANDA 061387 | — | Approved Prior to Jan 1, 1982 | |
| OMNIPEN (AMPICILLIN)×2 | WYETH AYERST | ANDA 060624 | — | Approved Prior to Jan 1, 1982 | |
| PENBRITIN×2 | WYETH AYERST | ANDA 060908 | — | Approved Prior to Jan 1, 1982 | |
| PFIZERPEN-A×2 | PFIZER | ANDA 062050 | — | Approved Prior to Jan 1, 1982 | |
| PRINCIPEN×2 | BRISTOL MYERS SQUIBB | ANDA 061392 | — | Approved Prior to Jan 1, 1982 | |
| PRINCIPEN '250'×2 | APOTHECON | ANDA 062157 | — | Approved Prior to Jan 1, 1982 | |
| TOTACILLIN×2 | GLAXOSMITHKLINE | ANDA 060060 | — | Approved Prior to Jan 1, 1982 | |
| TOTACILLIN×2 | GLAXOSMITHKLINE | ANDA 062212 | — | Approved Prior to Jan 1, 1982 | |
| AMCILL×2 | PARKE DAVIS | ANDA 062030 | — | Approved Prior to Jan 1, 1982 | |
| AMPICILLIN TRIHYDRATE×2 | BELCHER PHARMS | ANDA 061601 | — | Approved Prior to Jan 1, 1982 | |
| AMPICILLIN TRIHYDRATE×2 | MYLAN | ANDA 061829 | — | Approved Prior to Jan 1, 1982 | |
| AMPICILLIN TRIHYDRATE×2 | PUREPAC PHARM | ANDA 061980 | — | Approved Prior to Jan 1, 1982 | |
| AMPICILLIN TRIHYDRATE×2 | TEVA | ANDA 061370 | — | Approved Prior to Jan 1, 1982 | |
| OMNIPEN (AMPICILLIN)×4 | WYETH AYERST | ANDA 060625 | — | Approved Prior to Jan 1, 1982 | |
| PFIZERPEN-A×2 | PFIZER | ANDA 062049 | — | Approved Prior to Jan 1, 1982 | |
| POLYCILLIN×2 | APOTHECON | ANDA 062297 | — | Approved Prior to Jan 1, 1982 | |
| PRINCIPEN×3 | APOTHECON | ANDA 061394 | — | Approved Prior to Jan 1, 1982 | |
| PRINCIPEN '125'×2 | APOTHECON | ANDA 060127 | — | Approved Prior to Jan 1, 1982 | |
| PRINCIPEN '125'×2 | APOTHECON | ANDA 062151 | — | Approved Prior to Jan 1, 1982 | |
| TOTACILLIN×2 | GLAXOSMITHKLINE | ANDA 060666 | — | Approved Prior to Jan 1, 1982 | |
| TOTACILLIN×2 | GLAXOSMITHKLINE | ANDA 062223 | — | Approved Prior to Jan 1, 1982 |
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Ampicillin/ampicillin trihydrate — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

